NEW YORK (360Dx) – Accelerate Diagnostics reported after the market closed on Thursday that its fourth quarter revenues rose sharply year over year, but still fell short of the consensus Wall Street estimate.

For the three months ended Dec. 31, 2017, the company posted revenues of $2.1 million, compared to $39,000 in preliminary revenues for Q4 2016. The company  did not report final revenue figures a year ago. The growth in the recently completed quarter was driven by sales of the company's Pheno system and PhenoTest BC kit, Accelerate said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.